$224.69
2.80% day before yesterday
NYSE, Jun 06, 10:10 pm CET
ISIN
US9553061055
Symbol
WST

West Pharmaceutical Services, Inc. Stock price

$224.69
+19.33 9.41% 1M
-97.80 30.33% 6M
-102.87 31.40% YTD
-90.51 28.72% 1Y
+17.03 8.20% 5Y
+169.47 306.90% 10Y
+210.97 1,537.09% 20Y
NYSE, Closing price Fri, Jun 06 2025
+6.11 2.80%
ISIN
US9553061055
Symbol
WST
Sector

Key metrics

Market capitalization $16.14b
Enterprise Value $15.95b
P/E (TTM) P/E ratio 35.11
EV/FCF (TTM) EV/FCF 51.96
EV/Sales (TTM) EV/Sales 5.51
P/S ratio (TTM) P/S ratio 5.57
P/B ratio (TTM) P/B ratio 6.01
Dividend yield 0.36%
Last dividend (FY24) $0.82
Revenue growth (TTM) Revenue growth -1.12%
Revenue (TTM) Revenue $2.90b
EBIT (operating result TTM) EBIT $585.20m
Free Cash Flow (TTM) Free Cash Flow $306.90m
Cash position $404.20m
EPS (TTM) EPS $6.40
P/E forward 37.10
P/S forward 5.45
EV/Sales forward 5.39
Short interest 4.11%
Show more

Is West Pharmaceutical Services, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

13x Buy
81%
3x Hold
19%

Analyst Opinions

16 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy
81%
Hold
19%

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,896 2,896
1% 1%
100%
- Direct Costs 1,896 1,896
3% 3%
65%
1,000 1,000
8% 8%
35%
- Selling and Administrative Expenses 340 340
4% 4%
12%
- Research and Development Expense 68 68
2% 2%
2%
745 745
7% 7%
26%
- Depreciation and Amortization 160 160
13% 13%
6%
EBIT (Operating Income) EBIT 585 585
12% 12%
20%
Net Profit 467 467
18% 18%
16%

In millions USD.

Don't miss a Thing! We will send you all news about West Pharmaceutical Services, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

West Pharmaceutical Services, Inc. Stock News

Neutral
PRNewsWire
one day ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ex...
Neutral
PRNewsWire
2 days ago
NEW YORK , June 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. So what: If you purchased West Pharmaceutical common stock during the...
Neutral
PRNewsWire
2 days ago
LOS ANGELES , June 5, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) have opportunity to lead the securities fraud class action lawsuit.
More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office United States
CEO Eric Green
Employees 10,600
Founded 1923
Website www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today